The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引：8
|
作者：
Kaltsas, Gregory [1 ]
Grossman, Ashley B. [2 ]
机构：
[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 06期
关键词：
PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;
D O I：
10.1111/cen.12831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 50 条
  • [41] The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours
    Eriksson, B
    Janson, ET
    Bax, NDS
    Mignon, M
    Morant, R
    Opolon, P
    Rougier, P
    Oberg, KE
    DIGESTION, 1996, 57 : 77 - 80
  • [42] Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules
    Massironi, Sara
    Conte, Dario
    Rossi, Roberta Elisa
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (05) : 513 - 523
  • [43] Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
    Stueven, Anna Kathrin
    Kayser, Antonin
    Wetz, Christoph
    Amthauer, Holger
    Wree, Alexander
    Tacke, Frank
    Wiedenmann, Bertram
    Roderburg, Christoph
    Jann, Henning
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12):
  • [44] A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours
    de Araujo, E. B.
    Caldeira Filho, J. S.
    Nagamati, L. T.
    Muramoto, E.
    Colturato, M. T.
    Couto, R. M.
    Pujatti, P. B.
    Mengatti, J.
    Silva, C. P. G.
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (02) : 227 - 233
  • [45] MTOR ACTIVATION IN ADVANCED NEUROENDOCRINE TUMORS IN TREATMENT WITH SOMATOSTATIN ANALOGUES - A SINGLE CENTER STUDY
    Fernandes, I.
    Pacheco, T.
    Costa, A.
    Santos, A. C.
    Oliveira, A. G.
    Casimiro, S.
    Quintela, A.
    Fernandes, A.
    Ramos, M.
    Costa, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 264 - 265
  • [46] Resistance of neuroendocrine tumours to somatostatin analogs
    Angelousi, Anna
    Koumarianou, Anna
    Chatzellis, Eleftherios
    Kaltsas, Gregory
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2023, 18 (01) : 33 - 52
  • [47] Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours
    de Herder, WW
    Hofland, LJ
    van der Lely, AJ
    Lamberts, SWJ
    ENDOCRINE-RELATED CANCER, 2003, 10 (04) : 451 - 458
  • [48] Somatostatin analogues in digestive neuroendocrine tumors
    Cazan, Andreea
    Costache, Cristina
    Ispas, Maria
    Balaban, Vasile
    Barbu, Mihaela
    Smenger, Luiza
    Manuc, Teodora
    Dutei, Catalin
    Sburlan, Ioana
    Diculescu, Mircea
    Croitoru, Adina
    Manuc, Mircea
    XXXVI NATIONAL CONGRESS OF GASTROENTEROLOGY, HEPATOLOGY AND DIGESTIVE ENDOSCOPY, 2016, : 95 - 99
  • [49] The role of somatostatin analogues in the treatment of refractory diarrhoea
    Farthing, MJG
    DIGESTION, 1996, 57 : 107 - 113
  • [50] PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs)
    Ansquer, C.
    Taieb, D.
    Montravers, F.
    Tenenbaum, F.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (01): : 18 - 25
12345